Search

Displaying results 7201 - 7210 of 10000 in total
  1. Drug

    Demcizumab

    go.drugbank.com/drugs/DB12734
    Investigational

    Demcizumab is under investigation for the treatment of Nonsquamous Nonsmall Cell Neoplasm of Lung.

  2. Drug

    Ricolinostat

    go.drugbank.com/drugs/DB12376
    Investigational

    Ricolinostat is under investigation for the treatment of Breast Carcinoma and Metastatic Breast Cancer.

  3. Drug

    AMT-080

    go.drugbank.com/drugs/DB17846
    Experimental

    AMT-080 is an investigational gene therapy being investigated for the treatment of Duchenne muscular dystrophy.

  4. Drug

    2,3-Dimercapto-1-propanesulfonic acid

    go.drugbank.com/drugs/DB15967
    Investigational

    Categories: Compounds used in a research, industrial, or household setting
  5. Drug

    t-Butylhydroquinone

    go.drugbank.com/drugs/DB07726
    Experimental

    Categories: Compounds used in a research, industrial, or household setting
  6. Drug

    Methyl pyrrolidone

    go.drugbank.com/drugs/DB12521
    Investigational

    N Methyl Pyrrolidone is under investigation for the treatment of Multiple Myeloma.

    Synonyms: N-methylpyrrolidone, N-methyl-pyrrolidone
  7. Drug

    Aklavine

    go.drugbank.com/drugs/DB19070
    Experimental

    Aklavine is under investigation in clinical trial NCT03026842 (Decitabine Versus Conventional Chemotherapy for Maintenance Therapy of Acute Myeloid Leukemia With T(8;21)).

  8. Drug

    Melarsoprol

    go.drugbank.com/drugs/DB12864
    Investigational

    Melarsoprol is under investigation in clinical trial NCT00330148 (Randomized Clinical Trial of Three Drug Combinations for Late-Stage Gambiense Human African Trypanosomiasis).

  9. Drug

    Oxymatrine

    go.drugbank.com/drugs/DB16276
    Investigational

    Oxymatrine is under investigation in clinical trial NCT02202473 (Oxymatrine Plus Lamivudine Combination Therapy Versus Lamivudine Monotherapy for Chronic Hepatitis B Infected Subjects).

  10. Drug

    Finotonlimab

    go.drugbank.com/drugs/DB18859
    Investigational

    Finotonlimab is under investigation in clinical trial NCT04560894 (SCT-I10A Plus SCT510 Versus Sorafenib as First-line Therapy for Advanced Hepatocellular Carcinoma).